Top Markets
Coin of the day
Galderma Group AG Galderma Group AG

Galderma Group AG

GALD
Rangering i aksjer #474
Galderma Group AG operates as a dermatology company worldwide. The company... Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Aksjekurs
$228.90
Sist synkronisert: 2026-08-12
Markedsverdi
$53.38B
Endring (1 dag)
0.06%
Endring (1 år)
41.12%
Land
CH
Handel Galderma Group AG (GALD)

Kategori

P/S-forhold for Galderma Group AG (GALD)
P/S-forhold per 2026 TTM: 0
Ifølge Galderma Group AG sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for Galderma Group AG fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter